ABHD17A and cancer: More recently, regulation of the palmitoylation status of the transcription factor TEAD, which is depalmitoylased by ABHD17A, has been suggested to be a potential target for controlling TEAD-dependent processes, including cancer cell growth (Kim and Gumbiner 2019).